Hodgkin's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Hodgkin's Disease, including details on causes, cancer, lymphoma, stages, symptoms.

Volume 5 (2008), Issue 3 (March)

1. Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.
   J Med Genet, 45(3): 142-6. [Abstract] [Full-text]
2. Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma.
   J Clin Oncol, 26(8): 1282-8. [Abstract] [Full-text]
3. PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.
   Blood, 111(6): 3220-4. [Abstract] [Full-text]
4. Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients.
   Blood, 111(6): 2977-83. [Abstract] [Full-text]
5. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
   Biochem Pharmacol, 75(7): 1461-71. [Abstract] [Full-text]
6. Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome.
   Biol Blood Marrow Transplant, 14(4): 418-25. [Abstract] [Full-text]
7. ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study.
   Ann Oncol, 19(4): 763-8. [Abstract] [Full-text]

© 2004-2012 Hodgkin's Disease Research Today. All Rights Reserved.